Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Galindo-Campos MA"'
Autor:
Galindo-Campos MA; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Lutfi N; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Bonnin S; Center for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain., Martínez C; Experimental Pathology Unit, Instituto Murciano de Investigación Biosanitaria-Laboratorio de Investigación Biosanitaria-Arrixaca, Murcia, Spain., Velasco-Hernandez T; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Instituto de Salud Carlos III (ISCIII), Redes de Investigación Cooperativa Orientadas a Resultados en Salud, Madrid, Spain., García-Hernández V; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Martín-Caballero J; Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain., Ampurdanés C; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Gimeno R; Laboratory of Immunology, Department of Pathology., Colomo L; Department of Pathology, Hospital del Mar, Barcelona, Spain., Roué G; Josep Carreras Leukemia Research Institute, Barcelona, Spain., Guilbaud G; Division of Protein and Nucleic Acid Chemistry, Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom., Dantzer F; Biotechnology and Cell Signaling, Unité Mixte de Recherche (UMR) 7242 Centre National de la Recherche Scientifique, Laboratory of Excellence Medalis, École Supérieure de Biotechnologie de Strasbourg, Strasbourg University, Illkirch, France., Navarro P; Institute of Biomedical Research of Barcelona (IIBB)-CSIC, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain.; Hospital del Mar Medical Research Institute, Unidad Asociada IIBB-CSIC, Barcelona, Spain., Murga M; Genomic Instability Group, Spanish National Cancer Research Centre, Madrid, Spain., Fernández-Capetillo O; Genomic Instability Group, Spanish National Cancer Research Centre, Madrid, Spain.; Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Bigas A; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; ISCIII, Centro de Investigación Biomédica en Red de Oncología, Barcelona, Spain; and., Menéndez P; Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Instituto de Salud Carlos III (ISCIII), Redes de Investigación Cooperativa Orientadas a Resultados en Salud, Madrid, Spain.; ISCIII, Centro de Investigación Biomédica en Red de Oncología, Barcelona, Spain; and.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Sale JE; Division of Protein and Nucleic Acid Chemistry, Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom., Yélamos J; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; Laboratory of Immunology, Department of Pathology.
Publikováno v:
Blood [Blood] 2022 Jan 13; Vol. 139 (2), pp. 228-239.
Autor:
Lutfi N; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Galindo-Campos MA; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Yélamos J; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.; Immunology Unit, Department of Pathology, Hospital del Mar, 08003 Barcelona, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Nov 29; Vol. 13 (23). Date of Electronic Publication: 2021 Nov 29.
Autor:
Moreno-Lama L; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Galindo-Campos MA; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Martínez C; Experimental Pathology Unit, IMIB-LAIB-Arrixaca, Murcia, Spain., Comerma L; Department of Pathology, Hospital del Mar, Barcelona, Spain., Vazquez I; Department of Pathology, Hospital del Mar, Barcelona, Spain., Vernet-Tomas M; Department of Obstetrics and Gynecology, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Ampurdanés C; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Lutfi N; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Martin-Caballero J; Barcelona Biomedical Research Park (PRBB), Barcelona, Spain., Dantzer F; Biotechnology and Cell Signaling, UMR7242-CNRS, Laboratory of Excellence Medalis, ESBS, Illkirch, France., Quintela-Fandino M; Breast Cancer Clinical Research Unit, CNIO, Madrid, Spain., Ali SO; Oxford University Hospitals, NHS, Oxford, UK., Jimeno J; Department of General Surgery, Breast Unit, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Yélamos J; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. jyelamos@imim.es.; Department of Pathology, Hospital del Mar, Barcelona, Spain. jyelamos@imim.es.
Publikováno v:
Oncogene [Oncogene] 2020 Mar; Vol. 39 (13), pp. 2835-2843. Date of Electronic Publication: 2020 Jan 30.
Autor:
Galindo-Campos MA; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Bedora-Faure M; Genome Integrity, Immunity and Cancer Unit, Equipe Labellisée Ligue Contre le Cancer, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, 75015, Paris, France., Farrés J; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Lescale C; Genome Integrity, Immunity and Cancer Unit, Equipe Labellisée Ligue Contre le Cancer, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, 75015, Paris, France., Moreno-Lama L; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Martínez C; Experimental Pathology Unit, IMIB-LAIB-Arrixaca, Murcia, Spain., Martín-Caballero J; Barcelona Biomedical Research Park (PRBB), Barcelona, Spain., Ampurdanés C; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Aparicio P; Department of Biochemistry, Molecular Biology and Immunology, University of Murcia, Murcia, Spain., Dantzer F; Biotechnology and Cell Signaling, UMR7242-CNRS, Laboratory of Excellence Medalis, ESBS, Illkirch, France., Cerutti A; Catalan Institute for Research and Advanced Studies (ICREA), Barcelona, Spain.; Inflammatory and Cardiovascular Disorders Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Deriano L; Genome Integrity, Immunity and Cancer Unit, Equipe Labellisée Ligue Contre le Cancer, Department of Immunology, Department of Genomes and Genetics, Institut Pasteur, 75015, Paris, France. ludovic.deriano@pasteur.fr., Yélamos J; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. jyelamos@imim.es.; Department of Immunology, Hospital del Mar, Barcelona, Spain. jyelamos@imim.es.
Publikováno v:
Cell death and differentiation [Cell Death Differ] 2019 Dec; Vol. 26 (12), pp. 2667-2681. Date of Electronic Publication: 2019 Apr 17.
Autor:
Hardy-Werbin M; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), 08003 Barcelona, Spain. mhardy@imim.es., Del Rey-Vergara R; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), 08003 Barcelona, Spain. rdelrey@imim.es., Galindo-Campos MA; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), 08003 Barcelona, Spain. mgalindo@imim.es., Moliner L; Medical Oncology Department, Hospital del Mar-CIBERONC, 08003 Barcelona, Spain. lmoliner@psmar.cat., Arriola E; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), 08003 Barcelona, Spain. earriola@psmar.cat.; Medical Oncology Department, Hospital del Mar-CIBERONC, 08003 Barcelona, Spain. earriola@psmar.cat.
Publikováno v:
Cancers [Cancers (Basel)] 2019 Sep 20; Vol. 11 (10). Date of Electronic Publication: 2019 Sep 20.
PARP-1/PARP-2 double deficiency in mouse T cells results in faulty immune responses and T lymphomas.
Autor:
Navarro J; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Gozalbo-López B; Inmunología Viral, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain., Méndez AC; Inmunología Viral, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain., Dantzer F; Biotechnology and Cell Signaling, UMR7242-CNRS, Laboratory of Excellence Medalis, ESBS, Illkirch, France., Schreiber V; Biotechnology and Cell Signaling, UMR7242-CNRS, Laboratory of Excellence Medalis, ESBS, Illkirch, France., Martínez C; Experimental Pathology Unit, IMIB-LAIB-Arrixaca, Murcia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain., Arana DM; Inmunología Viral, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain., Farrés J; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Revilla-Nuin B; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.; Genomic Unit. IMIB-LAIB-Arrixaca, Murcia, Spain., Bueno MF; Inmunología Viral, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain., Ampurdanés C; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Galindo-Campos MA; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Knobel PA; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Segura-Bayona S; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Martin-Caballero J; Barcelona Biomedical Research Park (PRBB), Barcelona, Spain., Stracker TH; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Aparicio P; Department of Biochemistry, Molecular Biology and Immunology, University of Murcia, Murcia, Spain., Del Val M; Inmunología Viral, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain., Yélamos J; Cancer Research Program, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.; Department of Immunology, Hospital del Mar, Barcelona, Spain.
Publikováno v:
Scientific reports [Sci Rep] 2017 Feb 09; Vol. 7, pp. 41962. Date of Electronic Publication: 2017 Feb 09.
Autor:
Ali SO; School of Clinical Medicine, University of Cambridge Cambridge, UK., Khan FA; School of Clinical Medicine, University of Cambridge Cambridge, UK., Galindo-Campos MA; Department of Immunology, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) Barcelona, Spain., Yélamos J; Department of Immunology, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)Barcelona, Spain; CIBERehdSpain.
Publikováno v:
American journal of cancer research [Am J Cancer Res] 2016 Sep 01; Vol. 6 (9), pp. 1842-1863. Date of Electronic Publication: 2016 Sep 01 (Print Publication: 2016).